• Peter Kapitein

    Peter connects patients, researchers and clinicians to further research, treatments and care; in the Netherlands as well as internationally. He organises congresses, lobbies the matrix of public authorities, health care organisations, insurance companies and health research institutes. Peter also gives lectures and talks to help patients and society to fight cancer where possible and live with cancer with a good quality of life. He is a writer of blogs, articles and books that also contributes to these topics.


    Please log into your account to view faculty contact details.


    Email —  ******@***gmail.com
    President, Patient Advocate Inspire2Live, Amsterdam, the Netherlands —  Inspire2Live has been created to empower people to convert the sense of powerlessness, caused by cancer, into one of strength. Inspire2Live is founded on the absolute belief that one can attain the greatest possible satisfaction by putting their heart and soul into helping others. Its motto is “Never, ever quit!”.

Featured in HealthManagement.org

  • img

    Advocates, Let’s Make It Our Problem!

    I have lymphoma. Is that my problem or that of my physician? Or perhaps the problem of research and industry? It is indeed my problem and I need my physician badly. She can only do her work when...

    READ MORE
  • img

    Moving Evidence into Practice

    On 11 November 2021, Inspire2Live organised a congress in Amsterdam to determine the best patient screening, diagnosis, and treatment techniques for prostate cancer and how we can offer them to every

    READ MORE
  • img

    "We Can Do Better!"

    When Inspire2Live organised its first Annual Congress in 2011, José Baselga was one of the speakers, and he opened his speech with the following statement: “We are not meant to be here for 1- or...

    READ MORE
  • img

    Quality of Life for the Global Patient

    In our world live 7.8 billion people. Pharma only focuses on cancer treatments for 1.6 billion people. How can the other 6.2 billion people hold no interest for pharma? Even from a commercial perspec

    READ MORE
  • img

    Awareness, Education, Prevention and Government

    In September of this year, our group of international patient advocates and scholar-activists had a congress at the Royal Netherlands Academy of Arts and Sciences. We had several good discussions...

    READ MORE
  • img

    What About Post-Corona?

    Is there a time after COVID-19? Do you regularly hear the question of what we will do after COVID-19? Or what should we do? This is a strange question, because there will be no time after Corona

    READ MORE
  • img

    We Can Eradicate Cervical Cancer!

    Scientific knowledge eradicated smallpox, a painful and disfiguring disease which killed 300 million people in the 20th century alone. In case anyone has skimmed over this feat of moral greatness,...

    READ MORE
  • img

    Patient’s Voice to Cancel Cancer: When Accountability Becomes Responsi

    In the past decades something happened in healthcare that doesn’t benefit patients. Actually, it is what we patient advocates call ‘Dying is safer’. For some of the stakeholders in the medica

    READ MORE
  • img

    Patient’s Voice to Cancel Cancer: Autonomy for Patient and Oncologist

    Let’s start with a quip. When you want to become an oncologist, you only need three or four years of primary school. You need to be able to read and write. The pathologist will tell you what...

    READ MORE
  • img

    Patients’ Voice to Cancel Cancer: From Shooting In the Dark We Can Bec

    “Cancer is a mobile disease. It changes while you look at it. Treat it like tuberculosis; 4 drugs for one year, at the same time!” Professor David Tuveson, CSHL   We do

    READ MORE
  •  Maria Chacon, MSc

    Prevent or Treat in Latin America

    • 15/02/2021

    In Latin America there is a big need for prevention as many people do not have access to treatment due to high costs. Prevention not only in terms of becoming sick but also of not paying more than necessary. The situation varies across the continent, and in some countries there are good working examples. Still, the challenges of cancer in Latin America demand immediate action. By joining forces of...

    READ MORE
  • Dr. H.C. Peter Kapitein

    Is Patient Really Empowered in Medical Industrial Complex?

    • 12/11/2020

    A veteran patient advocate questions some of the hyped patient-engagement concepts and the reality of their practical applications within the ‘medical industrial complex’, and offers some strategies to change ‘the way we work’. Key Points In the medical industrial complex, stakeholders are distracted from the essence, i.e. the patient. There are many obstacles on the way to...

    READ MORE
  • Dr. H.C. Peter Kapitein

    Risks, Costs, Benefits and Trust in Healthcare - Why and When Do We Tr

    • 28/09/2020

    With artificial intelligence and personalised medicine playing an increasingly important role in today’s healthcare, one cannot help but wonder about the regulation of these fields. An expert analyses the pros and cons of the ‘checks and balances’ system that exists today and argues that too much regulation may result in negative patient outcomes. Key Points The two sides of any regulation,...

    READ MORE
  • Dr. H.C. Peter Kapitein

    ‘The Death of Cancer’ - The Patient Perspective

    • 26/08/2019

    Summary: Cancer affects everybody's life at some point. ‘The Death of Cancer,' written by one of oncology's leading figures, Dr Vincent T. DeVita, documents his own journey for the cure. Dr Peter Kapitein gives his personal review on the book.   In 2005 I was diagnosed with lymph gland cancer and became interested in the medical industrial complex: everything that has to do with healthcare...

    READ MORE
  • Dr. H.C. Peter Kapitein

    The need and speed of cooperation instead of competition in research

    • 22/09/2018

    Questions that need to be answered taking into account benefits for the patient. Academic rivalry is not in the patient’s interest, and as long as patients are not involved in healthcare and healthcare research on an equal basis there will be no solutions for the questions that need answering. Leó Szilárd wrote in 1948 The Mark Gable Foundation (Szilárd 1961). When asked by a wealthy...

    READ MORE
  • img

    Share our data: GDPR and the patient view

    The European Union’s (EU) General Data Protection Regulation (GDPR) took effect on 25 May. Directly binding and applicable in all EU states, the GDPR aims to protect the data and privacy of the...

    READ MORE
  •  James Mucklow

    General Data Protection Regulation and healthcare

    • 23/05/2018

    What could the new data protection law mean for health sector leaders? The European Union’s (EU) General Data Protection Regulation (GDPR) will take effect on 25 May 2018, replacing the 1995 Data Protection Directive. Directly binding and applicable in all EU states, the GDPR aims to protect the data and privacy of the European population by giving control back to citizens and to make the regulatory env

    READ MORE
  • Dr. H.C. Peter Kapitein

    The payer determines, but it is not the patient

    • 20/02/2018

    In healthcare patients are not consumers with the economic power they have in other markets, but the arguments for patient involvement are compelling. "Healthcare is like dog food business." Here we hear an American explaining that in healthcare, just like in buying dog food, the consumer is not the one who determines what is on the menu, nor the one who pays. Patients are not consumers in the...

    READ MORE
  • Dr. H.C. Peter Kapitein

    Responsible research innovation – heard of that before?

    • 19/09/2017

    A reminder about who is at the centre of the complex healthcare hierarchy and industry – the patient.   In May I was present at the excellent congress “Responsible Research and Innovation in the Health Industry”, organised among others by the EU Economic and Social Committee. I had the honour of speaking about my ideas on innovation and the obstacles that are connected with it. Of course...

    READ MORE
  • img

    There Might Be Too Much Money In Healthcare

    I was struck by a press announcement of the United States Food and Drug Administration of 23 May 2017: ‘ FDA approves first cancer treatment for any solid tumour with a specific genetic feature...

    READ MORE
  • Dr. H.C. Peter Kapitein

    Peter Kapitein

    • 07/05/2017

    Patient Advocate, Inspire2Live, Amsterdam, the Netherlands If about us, not without us Healthcare exists because we patients exist and therefore we should not only be asked about what we want, we should also decide about all matters in healthcare. Simply for the sake of the patients and their loved ones and for the sake of lower costs in healthcare. I’m...

    READ MORE
  • img

    Why Don’t We Introduce Patients Into Healthcare Management?

    “Good morning Mr. Smith. Good to see you, how are you doing? You’re looking for a new car? That’s good news. We decided that it’s going to be a Ford Focus, ST, 2.0 Eco-boost, 184 KW, 6-gear. Let’s...

    READ MORE
  • Dr. H.C. Peter Kapitein

    Does More Value Naturally Lead to Better Care?

    • 16/02/2017

    Value-based healthcare (VBHC) starts with the patient and uses patient-oriented outcomes to improve care. Not everything can be expressed in figures: psychological and sociological factors play a role as well. The medical-industrial complex does not always benefit from VBHC, which is the reason why the different interests are not always advantageous to the patient. With an approach that starts with...

    READ MORE
Subscribe To HealthManagement

Latest News

Movers & Shakers

Events